Skip to main content
    S

    Strata Critical Medical, Inc. (SRTA)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $5.42
    -0.09 (-1.63%)

    Market Cap: $492.15M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Strata Critical Medical, Inc. (SRTA) Financials: Revenue, Profit and Cash Flow

    Updated Nov 3, 2026. Financial statements from company filings, amounts in US dollars.

    Strata Critical Medical reported revenue of $197.14M for the fiscal year ended Dec 31, 2025, down 20.7% from the year before. That year, net income was $41.35M with a net margin of 21.0%, operating cash flow was -$48.91M and free cash flow was -$59.92M. The quarter ended Sep 30, 2026 had revenue of $74.08M and net income of -$7.62M.

    Revenue and Margins

    The operating margin was -11.3% in the fiscal year ended Dec 2025, the highest of the 7 years shown. Over the 6 years to Dec 2025, revenue grew from $31.20M, a compound annual rate of 36.0%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$197.14M-20.7%20.9%-11.3%21.0%
    Dec 2024$248.69M+10.4%23.7%-13.6%-11.0%
    Dec 2023$225.18M+54.1%18.7%-30.3%-24.9%
    Dec 2022$146.12M+189.2%15.2%-36.6%-18.7%
    Dec 2021$50.53M+115.6%20.8%-47.7%-79.3%
    Dec 2020$23.43M-24.9%9.9%-44.2%-43.4%
    Dec 2019$31.20MN/A15.1%-37.0%-34.7%
    Annual, fiscal years ended Dec 2019 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, the company posted a net loss after a profit in the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Revenue$197.14M$248.69M$225.18M$146.12M$50.53M$23.43M$31.20M
    Cost of revenue$156.01M$189.77M$183.06M$123.84M$40.01M$21.11M$26.50M
    Gross profit$41.13M$58.92M$42.12M$22.27M$10.52M$2.33M$4.70M
    Research and development$3.05M$3.18M$4.63M$5.54M$1.68M$861.00K$751.00K
    Operating income-$22.35M-$33.93M-$68.12M-$53.53M-$24.09M-$10.36M-$11.54M
    Net income$41.35M-$27.31M-$56.08M-$27.26M-$40.05M-$10.16M-$10.84M
    EBITDA-$5.71M-$21.60M-$50.43M-$22.31MN/A-$9.83M-$11.07M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$74.08M$72.51M$67.38M$66.79M$49.30M$70.80M$54.31M$54.36M$74.88M$67.94M$51.51M$47.48M
    Gross profit$16.82M$15.21M$14.12M$11.67M$11.61M$17.74M$11.98M$12.59M$19.84M$16.35M$10.14M$9.01M
    Operating income-$3.83M-$5.41M-$2.97M-$6.41M-$5.62M-$4.95M-$7.58M-$8.37M-$3.54M-$12.15M-$9.87M-$35.63M
    Net income-$7.62M-$10.52M$2.15M-$8.83M$57.42M-$3.74M-$3.49M-$9.79M-$1.95M-$11.33M-$4.23M-$33.94M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $652.00K by $30.32M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Total assets$325.47M$256.68M$294.94M$325.02M$335.88M$17.71M$277.69M
    Current assets$126.19M$160.74M$206.26M$218.13M$294.94M$14.38M$1.43M
    Cash and equivalents$30.97M$18.38M$27.87M$41.34M$2.60M$12.16M$1.31M
    Total liabilities$46.40M$34.74M$60.64M$50.54M$44.51M$6.63M$272.69M
    Short-term debt$652.00K$3.30M$4.79M$3.36M$438.00K$1.59M$231.37K
    Shareholder equity$279.07M$221.94M$234.30M$274.49M$291.37M$11.08M$5.00M
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$328.88M$332.70M$327.62M$325.47M$335.08M$257.92M$250.55M$256.68M$282.94M$280.33M$282.79M$294.94M
    Total liabilities$52.51M$53.38M$41.89M$46.40M$52.08M$34.82M$30.82M$34.74M$49.45M$50.95M$46.18M$60.64M
    Cash and equivalents$35.14M$16.32M$58.72M$30.97M$22.75M$58.75M$34.83M$18.38M$20.03M$26.31M$36.76M$27.87M
    Shareholder equity$276.38M$279.32M$285.73M$279.07M$283.00M$223.10M$219.73M$221.94M$233.50M$229.39M$236.61M$234.30M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
    Operating cash flow-$48.91M-$2.52M-$32.35M-$37.13M-$15.62M-$10.82M-$10.30M
    Capital expenditures$11.01M$32.99M$2.11M$730.00K$297.00K$377.00K$854.00K
    Free cash flow-$59.92M-$35.51M-$34.46M-$37.86M-$15.91M-$11.20M-$11.16M
    Investing cash flow$69.75M-$1.02M$17.09M$79.34M-$321.34M-$377.00K-$1.05M
    Financing cash flow-$8.91M-$5.76M-$76.00K-$1.08M$332.26M$1.18M$116.00K
    Fiscal years ended Dec 2019 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$9.46M$5.69M$3.56M-$8.31M-$31.84M-$3.06M-$246.00K$13.00K$6.36M$7.44M-$15.55M-$9.32M
    Capital expenditures$400.00K$2.19M$5.48M$2.00M$3.13M$2.73M$3.15M$5.04M$9.91M$16.91M$1.13M$24.00K
    Free cash flow$9.06M$3.50M-$1.93M-$10.31M-$34.97M-$5.80M-$3.39M-$5.03M-$3.56M-$9.46M-$16.68M-$9.34M
    Last 12 quarters

    Frequently Asked Questions About SRTA

    What is Strata Critical Medical's annual revenue?

    Strata Critical Medical reported revenue of $197.14M for the fiscal year ended Dec 31, 2025.

    How fast is Strata Critical Medical's revenue growing?

    Revenue was down 20.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 10.5%.

    Is Strata Critical Medical profitable?

    Yes. Strata Critical Medical reported net income of $41.35M for the fiscal year ended Dec 31, 2025, with a net margin of 21.0%.

    How much free cash flow does SRTA generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$48.91M minus capital expenditures of $11.01M produced free cash flow of -$59.92M.

    How much debt does Strata Critical Medical have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $652.00K and cash and equivalents of $30.97M.